Skip to main content

Advertisement

Log in

Prescription Contraceptive Sales Following the Affordable Care Act

Maternal and Child Health Journal Aims and scope Submit manuscript

Abstract

Objectives We examine trends in prescription contraceptive sales following the Affordable Care Act’s (ACA) zero-copayment contraceptive coverage mandate in areas more likely to be affected by the provision relative to areas less likely to be affected. Methods Before the ACA, several states had their own contraceptive insurance coverage mandates. Using a national prescription claims database combined with wholesaler institutional sales activity from January 2008 through June 2014, we compare sales of the intrauterine device (IUD), implant, injectable, pill, ring, and patch in states that had a state-level insurance coverage mandate before the ACA to states that did not. Results Overall, our results imply the ACA increased sales of prescription contraceptives, with stronger effects for some methods than others. Specifically, we find the ACA increased sales of injectable contraceptives, but had no significant impact on sales of the IUD, implant, pill, or patch in states without a state-level mandate before the ACA relative to states that had a state-level mandate. We also find suggestive evidence of a reduction in sales of the ring. Conclusions for Practice Demand responses to changes in out-of-pocket expenses for contraception vary across methods. Eliminating copays could promote the use of contraceptives, but is not the only approach to increasing contraceptive utilization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Source Symphony Health Solutions’ Pharmaceutical Audit Suite (PHAST), January 2008–June 2014

Fig. 2

Source Symphony Health Solutions’ Pharmaceutical Audit Suite (PHAST), January 2008–June 2014. Note that these two graphs are scaled differently to clearly show differences in trends

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lindsey Rose Bullinger.

Ethics declarations

Conflict of interest

No conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 92 KB)

Supplementary material 2 (DOCX 13 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bullinger, L.R., Simon, K. Prescription Contraceptive Sales Following the Affordable Care Act. Matern Child Health J 23, 657–666 (2019). https://doi.org/10.1007/s10995-018-2680-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10995-018-2680-1

Keywords

Navigation